Home › Funds › Parkman Healthcare Partners LLC › ANRO

Parkman Healthcare Partners LLC position in ANRO

ALTO NEUROSCIENCE INC · Health Care

Parkman Healthcare Partners LLC reported holding 948,863 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 2.19% of its reported portfolio and ranking #11 among its reported holdings. Parkman Healthcare Partners LLC has disclosed ANRO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)948.86K sh
Reported value held$24.22M
Portfolio Weight2.19%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's ANRO position evolved

Parkman Healthcare Partners LLC first disclosed a stake in ANRO in Q2 2026 at 429,035 shares (US$11.3M). The position peaked in Q3 2026 at 948,863 shares, worth US$24.2M. Across 2 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 948,863 shares valued at US$24.2M — an increase of 519,828 shares quarter over quarter.. Notable position changes include a 121% increase in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 429.04K $11.32M New
Q3 2026 948.86K $24.22M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 62 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$94.7M), Commodore Capital LP (US$71.9M), EcoR1 Capital, LLC (US$57.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held ANRO?

Parkman Healthcare Partners LLC has disclosed ANRO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Parkman Healthcare Partners LLC's current position in ANRO?

As of Q3 2026, Parkman Healthcare Partners LLC holds 948.86K shares of ANRO (ALTO NEUROSCIENCE INC), valued at $24.22M, representing 2.19% of its reported portfolio and ranking #11.

Has Parkman Healthcare Partners LLC been buying or selling ANRO?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in ANRO. The position peaked in Q3 2026 at 948.86K shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, EcoR1 Capital, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.